通用名称

doxycycline hyclate

儿科标签批准日期

2020/3/4 0:00:00

特定指示/秒

Postmarketing study

标签更改摘要

- Population pharmacokinetic analysis of sparse concentration-time data of doxycycline following standard of care intravenous and oral dosing in 44 children (2-18 years) showed that allometrically-scaled clearance of doxycycline in children ≥2 to ≤8 years did not differ significantly from children >8 to 18 years. - No clinically significant difference in CL differences between oral and IV were observed in the small cohort of pediatric patients who received the oral (N=19) or IV (N=21) formulation alone. - Off-patent written request.

治疗类别

Anti-Infective

立法类型

409I(BPCA)

产品说明书链接

书号

N/A

研究年龄

N/A

学习类型

N/A

研究设计

N/A

登记的患者

N/A

患者分析

N/A

中心的数量

N/A

国家数量

N/A

西班牙裔拉美裔/拉丁裔总计

N/A

非西班牙裔/非拉丁裔总人数

N/A

总数#种族不明

N/A

亚裔学生总数

N/A

黑人总数

N/A

白人总数

N/A

夏威夷或太平洋岛民总数

N/A

美洲印第安人/阿拉斯加本地人总数

N/A

其他种族总计

N/A

未知种族总数

N/A

国家

N/A